Study of Immune Responses to Influenza Vaccination
Who is this study for? Patients with Influenza
What treatments are being studied? Influenza Vaccination
Status: Recruiting
Location: See location...
Intervention Type: Biological
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
Better understanding of the immune responses to influenza vaccination is needed in order to understand situations of poor vaccine response. Adults will receive influenza vaccination and then have peripheral blood drawn at pre-defined intervals in order to study the lymphocyte responses.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
• Community-dwelling adults able to provide consent who need influenza vaccination for standard of care
Locations
United States
Pennsylvania
University of Pennsylvania
RECRUITING
Philadelphia
Contact Information
Primary
Sokratis Apostolidis, MD
sokratis.apostolidis@pennmedicine.upenn.edu
267-584-6653
Backup
E.John Wherry, PhD
wherry@pennmedicine.upenn.edu
Time Frame
Start Date: 2017-10-20
Estimated Completion Date: 2026-07-01
Participants
Target number of participants: 75
Treatments
Experimental: Influenza vaccination cohort
Adults will receive one intramuscular dose of seasonal quadrivalent inactivated influenza vaccine, as indicated for standard of care.
Related Therapeutic Areas
Sponsors
Leads: University of Pennsylvania